Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Description

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Conditions

Hematopoietic Stem Cell Transplantation, Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Condition
Hematopoietic Stem Cell Transplantation
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;
  • 2. Age 18 or older;
  • 3. English, Hindi, or Swahili speaking;
  • 4. Able to sign a written informed consent and be willing to follow protocol requirements.
  • * Extreme mobility issues that preclude participating in the YT;
  • * Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;
  • * HCT comorbidity score of 3 or higher, excluding cancer diagnoses

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Lorenzo Cohen, PHD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2026-01-31